Simpson Thacher represented CSL Behring in the transaction. CSL Behring executed its acquisition of Vitaeris Inc., a clinical-stage biotechnology company focused on the phase III development…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
